Hologic (HOLX) PT Lowered to $48 at Canaccord Genuity Following 1Q Results
Tweet Send to a Friend
Canaccord Genuity lowered its price target on Hologic (NASDAQ: HOLX) to $48.00 (from $50.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
